| AQP | aquaporin |
| NPA | Asn-Pro-Ala |
| Å | Ångstrom |
| CNS | central nervous system |
| MIP | major intrinsic protein |
| RNA | ribonucleic acid |
| cRNA | complementary ribonucleic acid |
| MMP | matrix metalloproteinase |
| cAMP | cyclic adenosine monophosphate |
| PKA | protein kinase A |
| NDI | nephrogenic diabetes insipidus |
| KO | knock-out |
| BBB | blood–brain barrier |
| ICP | intracranial pressure |
| NMO | neuromyelitis optica |
| MS | multiple sclerosis |
| AEDs | anti-epileptic drugs |
| miRNA | micro ribonucleic acid |
| siRNA | small interfering ribonucleic acid |
| TEA | tetraethylammonium |
| µM | micromolar |
| HEK293 | human embryonic kidney 293 |
| MCAO | middle cerebral artery occlusion |
| IC50 | half maximal inhibitory concentration |
| NiCl2 | nickel chloride |
| mM | millimolar |
| GFP | green fluorescent protein |
| hAQP | human aquaporin |
| calcein-AM | calcein acetoxymethyl |
| AgNO3 | silver nitrate |
| AgSul | silver sulfadiazine |
| IgG | immunoglobulin G |
| mRNA | messenger ribonucleic acid |
| qPCR | quantitative polymerase chain reaction |
| ELISA | enzyme-linked immunosorbent assay |
| nM | nanomolar |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activate B cells |
| IKK-β | inhibitor of nuclear factor kappa-B |
| 24h | 24 hours |
| TBI | traumatic brain injury |
| mBI | mild brain injury |
| TNF-α | tumor necrosis factor alpha |
| IL1 | interleukin 1 |
| IL6 | interleukin 6 |
| UMIN | University Hospital Medical Information Network |